Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 325

The DOI matches its Crossref record.

Type B Hepatitis after Needle-Stick Exposure: Prevention with Hepatitis B Immune Globulin: Final Report of the Veterans Administration Cooperative Study

SEEFF, L. B., WRIGHT, E. C., ZIMMERMAN, H. J., ALTER, H. J., DIETZ, A. A., FELSHER, B. F., FINKELSTEIN, J. D., GARCIA-PONT, P., GERIN, J. L., GREENLEE, H. B., HAMILTON, J., HOLLAND, P. V., KAPLAN, P. M., KIERNAN, T., KOFF, R. S., LEEVY, C. M., McAULIFFE, V. J., NATH, N., PURCELL, R. H., SCHIFF, E. R., SCHWARTZ, C. C., TAMBURRO, C. H., VLAHCEVIC, Z., ZEMEL, R., ZIMMON, D. S.·1978·Annals of Internal Medicine

Abstract

Hepatitis B immune globulin (HBIG) and immune serum globulin (ISG) were examined in a randomized, double-blind trial to assess their relative efficacies in preventing type B hepatitis after needle-stick exposure to hepatitis B surface antigen (HBsAG)-positive donors. Clinical hepatitis developed in 1.4% of HBIG and in 5.9% of ISG recipients (P = 0.016), and seroconversion (anti-HBs) occurred in 5.6% and 20.7% of them respectively (P less than 0.001). Mild and transient side-effects were noted in 3.0% of ISG and in 3.2% of HBIG recipients. Available donor sera were examined for DNA polymerase (DNAP) and e antigen and antibody (HBeAg; anti-HBE). Both DNAP and HBeAg showed a highly statistically significant correlation with the infectivity of HBsAg-positive donors. Hepatitis B immune globulin remained significantly superior to ISG in preventing type B hepatitis even when the analysis was confined to these two high-risk subgroups. The efficacy of ISG in preventing type B hepatitis cannot be ascertained because a true placebo group was not included.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-88-3-285

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 325

Metadata

Authors
SEEFF, L. B., WRIGHT, E. C., ZIMMERMAN, H. J., ALTER, H. J., DIETZ, A. A., FELSHER, B. F., FINKELSTEIN, J. D., GARCIA-PONT, P., GERIN, J. L., GREENLEE, H. B., HAMILTON, J., HOLLAND, P. V., KAPLAN, P. M., KIERNAN, T., KOFF, R. S., LEEVY, C. M., McAULIFFE, V. J., NATH, N., PURCELL, R. H., SCHIFF, E. R., SCHWARTZ, C. C., TAMBURRO, C. H., VLAHCEVIC, Z., ZEMEL, R., & ZIMMON, D. S.
Venue
Annals of Internal Medicine
Published
1978-03-01
Volume
88
Issue
3
Pages
285-293
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2169864175
Cited by
325
References
0
FWCI
20.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type B Hepatitis after Needle-Stick Exposure: Prevention with Hepatitis B Immune Globulin: Final Report of the Veterans Administration Cooperative Study. https://app.cochat.ai/papers/10.7326/0003-4819-88-3-285
The paper
SEEFF, L. B., WRIGHT, E. C., ZIMMERMAN, H. J., ALTER, H. J., DIETZ, A. A., FELSHER, B. F., FINKELSTEIN, J. D., GARCIA-PONT, P., GERIN, J. L., GREENLEE, H. B., HAMILTON, J., HOLLAND, P. V., KAPLAN, P. M., KIERNAN, T., KOFF, R. S., LEEVY, C. M., McAULIFFE, V. J., NATH, N., PURCELL, R. H., . . . ZIMMON, D. S. (1978). Type B Hepatitis after Needle-Stick Exposure: Prevention with Hepatitis B Immune Globulin: Final Report of the Veterans Administration Cooperative Study. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-88-3-285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.